Take a look at the chart included in a preview note published by J.P. Morgan's analysts. The data, itself, come from Bloomberg.J.P. Morgan:
I would have preferred to see the analysis conducted with the more inclusive Nasdaq Biotechnology Index (NBI) because the BTK tracks fewer stocks.
We assessed BTK performance relative to the S&P 500 during the week of the J.P. Morgan Healthcare Conference over the past 13 years. We observed that 85% of the time (all but 2 years), the BTK outperformed the S&P 500. From Monday to Friday during the week of the conference, the BTK increased on average by 3.0%, vs. flat S&P 500. Thus, the BTK outperformed the S&P 500 by ~2.9% on average during the week of the conference over the past 13 years
-- Reported by Adam Feuerstein in Boston.Follow Adam Feuerstein on Twitter.
03/14/14 - 10:54 AM EDT
03/12/14 - 11:03 AM EDT
03/12/14 - 09:57 AM EDT
03/06/14 - 10:14 AM EST
03/04/14 - 09:33 AM EST
03/14/14 - 11:04 AM EDT
03/13/14 - 11:24 AM EDT
03/12/14 - 12:00 PM EDT
03/12/14 - 11:39 AM EDT
03/11/14 - 11:41 AM EDT
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.